文献速递主动脉疾病

开窗/分支腔内修复退行性主动脉瘤后再干预分析

Reinterventions after fenestrated and branched endografting for degenerative aortic aneurysms.
PubMed 文献 · J Vasc Surg · 2021-06-02

本研究前瞻性纳入2006至2019年因近肾/肾旁腹主动脉瘤或胸腹主动脉瘤行开窗/分支腔内修复(F/B-EVAR)的连续患者,回顾分析再干预情况。中位随访27个月,41例接受52次再干预,3年免于再干预率81%、生存率75%,再干预者3年生存更低。

要点

  • 再干预多与靶内脏血管相关,多数可择期经腔内完成。
  • 胸腹主动脉瘤及急诊F/B-EVAR后再干预更频繁且影响生存。
  • 术前慢性肾功能衰竭、胸腹主动脉瘤、急诊手术为晚期死亡独立预测因素。

核心结论

  • F/B-EVAR后再干预并不少见,仅约一半与靶内脏血管相关,多数可择期经腔内技术完成,技术成功率良好。
  • 胸腹主动脉瘤与急诊F/B-EVAR后再干预更频繁,并显著影响总体生存。

研究设计与样本

  • 2006至2019年前瞻性纳入因近肾/肾旁腹主动脉瘤或胸腹主动脉瘤行F/B-EVAR的连续患者,排除主动脉夹层,回顾分析需再干预病例。
  • 共221例F/B-EVAR,近肾/肾旁腹主动脉瘤111例(50.3%)、胸腹主动脉瘤110例(49.7%);择期182例(82%)、急诊39例(18%);中位随访27个月(四分位距13个月)。

主要发现

  • 41例患者接受52次再干预:单次30例(14%)、多次11例(5%);通路相关17次(33%)、主髂动脉相关6次(12%)、靶内脏血管相关29次(55%)。
  • 52次再干预中32次(62%)在30天内、20次(38%)在30天后;急诊设置8次(15%);腔内32次(62%)、开放20次(38%)。
  • 开放再干预多为通路相关(通路16例、非通路4例,P ≤ .001);技术成功39例(95%),失败为1例脾动脉破裂和1例肾动脉丧失。
  • 再干预者更多为急诊初次F/B-EVAR(急诊12/39[31%] vs 择期29/182[16%],P < .001)及胸腹主动脉瘤(34/41[83%] vs 7/41[17%],P < .001)。
  • 胸腹主动脉瘤较近肾/肾旁腹主动脉瘤靶内脏血管相关再干预更多(26/28[93%] vs 2/28[7%],P < .001)、多次再干预更多(9/11[82%] vs 2/11[18%],P = .03)。

临床怎么用

  • 对胸腹主动脉瘤及急诊F/B-EVAR患者应加强随访监测再干预,尤其关注靶内脏血管。
  • 再干预多可择期经腔内完成,通路相关开放再干预需提前防范。
  • 合并术前慢性肾功能衰竭者需重视远期生存风险。

局限性

  • 为单中心前瞻性队列的回顾性再干预分析,样本量有限。
  • 随访中位仅27个月,缺乏长期结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Fenestrated/branched endovascular abdominal aortic aneurysm repair (F/B-EVAR) is widely accepted technique to treat juxta/pararenal abdominal aortic aneurysms (J/P-AAAs) and thoracoabdominal aortic aneurysms (TAAAs) for patients at high-surgical risk. However, the follow-up results should be carefully evaluated, especially in terms of the reintervention rate. The aim of the present study was, therefore, to evaluate the early and mid-term reinterventions after FB-EVAR for J/P-AAAs and TAAAs and their effects on follow-up survival. METHODS: From 2006 to 2019, all consecutive patients who had undergone F/B-EVAR for J/P-AAAs or TAAAs were prospectively enrolled. Cases requiring reinterventions were retrospectively analyzed. Patients with aortic dissection were excluded from the present analysis. Reinterventions were classified as follows: access related, aortoiliac related, or target visceral vessel (TVV) related. Freedom from reintervention and survival were assessed using the Kaplan-Meier method, and univariate and multivariate analyses were used to determine the risk factors. RESULTS: Overall, 221 F/B-EVAR procedures were performed for 111 J/P-AAAs (50.3%) and 110 TAAAs (49.7%) in an elective (182; 82%) or urgent (39; 18%) setting. The median follow-up was 27 months (interquartile range, 13 months). Overall, 41 patients had undergone 52 reinterventions (single, 30 [14%]; multiple, 11 [5%]; access related, 17 [33%]; aortoiliac related, 6 [12%]; TVV related, 29 [55%]). Of the 52 reinterventions, 32 (62%) and 20 (38%) had occurred within and after 30 days, respectively. Eight reinterventions (15%) had been were performed in an urgent setting. Endovascular and open reinterventions were performed in 32 (62%) and 20 (38%) cases, respectively. Open reinterventions were frequently access related (access, 16; no access, 4; P ≤ .001). Technical success was 95% (39 patients); failures consisted of one splenic artery rupture and one renal artery loss. Patients undergoing reintervention had more frequently undergone a primary urgent F/B-EVAR (urgent, 12 of 39 [31%]; elective, 29 of 182 [16%]; P < .001) and had had TAAAs (TAAAs, 34 of 41 [83%]; J/P-AAAs, 7 of 41 [17%]; P < .001). The patients with TAAAs had had a greater incidence of TVV-related reintervention (TAAAs, 26 of 28 [93%]; J/P-AAAs, 2 of 28 [7%]; P < .001) and multiple reinterventions (TAAAs, 9 of 11 [82%]; J/P-AAAs, 2 of 11 [18%]; P = .03) compared with those with J/P-AAAs. Survival at 3 years was 75%. Freedom from reintervention was 81% at 3 years. Patients who had undergone reinterventions had lower 3-year survival (reintervention, 61%; no reintervention, 77%; P = .02). Preoperative chronic renal failure (hazard ratio [HR], 2.0; 95% confidence interval [CI], 1.1-3.6; P = .02), TAAAs (HR, 2.3; 95% CI, 1.1-4.8; P = .03), and urgent primary F/B-EVAR procedures (HR, 2.5; 95% CI, 1.2-4.9; P = .01) were independent predictors of late mortality. CONCLUSIONS: Reinterventions after F/B-EVAR are not uncommon and were related to TVVs in only one half of cases. Most of them can be performed in an elective setting using endovascular techniques. The technical success rate was excellent. Reinterventions were more frequent after TAAAs and urgent F/B-EVAR procedures and had a significant effect on overall survival in these situations.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Gallitto E, Faggioli G, Pini R, et al. Reinterventions after fenestrated and branched endografting for degenerative aortic aneurysms. J Vasc Surg. 2021. PMID: 34087395. doi:10.1016/j.jvs.2021.05.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。